Press Releases

BOCA RATON, Fla., Feb. 3, 2020 /PRNewswire/ -- MDVIP, the national leader in affordable personalized healthcare, today announced the opening of two new MDVIP-affiliated primary care practices in Marriottsville, Maryland. Board certified internal medicine physicians

PLYMOUTH MEETING, Pa., Feb. 3, 2020 /PRNewswire/ -- Harmony Biosciences, LLC ("Harmony"), a private pharmaceutical company dedicated to developing and commercializing novel treatment options for people living with rare diseases, announced today that the company has been certified as a great workplace for the second year in a row by independent a

SOUTH PLAINFIELD, N.J., Feb. 3, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will host a conference call on Thursday, February 6, 2020, at 8:00 am ET highlighting data on risdiplam in type 2/3 spinal muscular atrophy patients from part 2 of the SUNFISH t

NEW YORK, Feb. 3, 2020 /PRNewswire/ -- The Vilcek Foundation is pleased to announce the winners of the 2020 Vilcek Prizes in Biomedical Science. Awarded annually, the Vilcek Prizes in Biomedical Science honor the contributions of immigrants to scientific research, discovery, and innovation in the United States. The Vilcek Prizes in

NEW YORK, Feb. 3, 2020 /PRNewswire/ -- A machine-learning algorithm developed by an orthopedic surgeon at Hospital for Special Surgery (HSS) and his colleagues identified predictive factors associated with worse outcomes for patients with

SAN JOSE, Calif., Feb. 3, 2020 /PRNewswire/ -- Quantum Corporation (NASDAQ: QMCO) today announced it has entered into an agreement with Western Digital Technologies, Inc., a subsidiary of Western Digital Corp. (NASDAQ: WDC), to acquire its ActiveScale™ 

NASHVILLE, Tenn., Feb. 3, 2020 /PRNewswire/ -- A new children's book, Fritzy Finds a Hat, written by 

SAN FRANCISCO, Feb. 3, 2020 /PRNewswire/ -- Nektar Therapeutics (NASDAQ: NKTR) today announced the publication of preclinical data on its lead immuno-oncology candidate, NKTR-214, bempegaldesleukin (bempeg) in two manuscripts in Nature Communications. Bempeg is an investigational CD122-preferential interleukin-2 (IL-2) pathway agonist designed to prov

PLYMOUTH MEETING, Pa., Feb. 3, 2020 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced publication of data from its pilot clinical study of INO-3106, a novel DNA therapy targeting human papilloma virus type 6 (HPV 6) for the treatment of recurrent respiratory papillomatosis (RRP), a rare and orphan disease, in the open access scientific journal

SOUTH PLAINFIELD, N.J., Feb. 3, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ:PTCT) today announced real-world data showing that boys with nonsense mutation Duchenne muscular dystrophy treated with Translarna™ (ataluren) and standard of care (SoC), preserved the ability to walk for years longer than those on SoC alone. Pulmonary function was also preser